Chemical Industry FDA Approves Teva’s Weltruza: A Paradigm Shift in Schizophrenia Management and Long-Acting Injectables WASHINGTON — In a milestone decision for neuropsychiatric care, the US Food and Drug Administration… Nana WuOctober 12, 2026
Chemical Industry Sanofi and Regeneron Deepen Historic Alliance with $8bn Agreement for Next-Generation Long-Acting Antibodies PARIS & TARRYTOWN, N.Y. — In one of the biopharmaceutical sector’s most enduring and lucrative… Laily UPNOctober 1, 2026